Douglas L Braunstein Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Douglas L Braunstein.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Douglas L Braunstein. Douglas L Braunstein is Chief Financial Officer in JPMORGAN CHASE & CO ($JPM) and Director in USA TECHNOLOGIES INC ($USAT) and Director in EAGLE PHARMACEUTICALS, INC. ($EGRX) and Director in Corindus Vascular Robotics, Inc. ($CVRS).
Latest Insider Trading Transactions of Douglas L Braunstein
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, USAT, CVRS, EGRX, JPM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 22 2020 | USAT | USA TECHNOLOGIES I ... | Braunstein Douglas L | Director | Option Exercise | A | 6.49 | 120,000 | 778,800 | 120,000 | |
| May 22 2020 | USAT | USA TECHNOLOGIES I ... | Braunstein Douglas L | Director | Option Exercise | A | 6.49 | 120,000 | 778,800 | 120,000 | |
| May 08 2020 | USAT | USA TECHNOLOGIES I ... | Braunstein Douglas L | Director | Grant | A | 0.00 | 15,409 | 0 | 15,409 | 0 to 15.4 K |
| Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Option Exercise | D | 1.40 | 4,725,000 | 6,615,000 | 0 | |
| Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Option Exercise | D | 1.40 | 4,725,000 | 6,615,000 | 0 | |
| Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Option Exercise | D | 1.25 | 105,281 | 131,601 | 0 | |
| Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Option Exercise | D | 1.25 | 105,281 | 131,601 | 0 | |
| Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Option Exercise | D | 1.25 | 540,000 | 675,000 | 0 | |
| Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Option Exercise | D | 1.25 | 540,000 | 675,000 | 0 | |
| Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Sell | D | 4.28 | 14,235,545 | 60,928,133 | 0 | 14.2 M to 0 (-100.00 %) |
| Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Sell | D | 4.28 | 14,235,545 | 60,928,133 | 0 | 14.2 M to 0 (-100.00 %) |
| Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Sell | D | 4.28 | 106,219 | 454,617 | 0 | 106.2 K to 0 (-100.00 %) |
| Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Sell | D | 4.28 | 106,219 | 454,617 | 0 | 106.2 K to 0 (-100.00 %) |
| Oct 09 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 4.27 | 1,170 | 4,996 | 106,219 | 105 K to 106.2 K (+1.11 %) |
| Jul 10 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 3.44 | 1,453 | 4,998 | 105,049 | 103.6 K to 105 K (+1.40 %) |
| May 13 2019 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Sell | S | 56.14 | 100,000 | 5,614,000 | 811,777 | 911.8 K to 811.8 K (-10.97 %) |
| May 13 2019 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Sell | S | 56.14 | 100,000 | 5,614,000 | 811,777 | 911.8 K to 811.8 K (-10.97 %) |
| May 13 2019 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Sell | S | 57.95 | 59,223 | 3,431,973 | 911,777 | 971 K to 911.8 K (-6.10 %) |
| May 13 2019 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Sell | S | 57.95 | 59,223 | 3,431,973 | 911,777 | 971 K to 911.8 K (-6.10 %) |
| May 07 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 2.17 | 27,649 | 59,998 | 103,596 | 75.9 K to 103.6 K (+36.41 %) |
| Apr 09 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 2.12 | 2,358 | 4,999 | 75,947 | 73.6 K to 75.9 K (+3.20 %) |
| Mar 14 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Buy | P | 1.38 | 2,899,391 | 4,000,000 | 14,235,545 | 11.3 M to 14.2 M (+25.58 %) |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Option Exercise | A | 42.40 | 10,000 | 424,000 | 10,000 | |
| Jan 10 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 1.12 | 5,357 | 6,000 | 73,589 | 68.2 K to 73.6 K (+7.85 %) |
| Oct 09 2018 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 1.25 | 3,200 | 4,000 | 68,232 | 65 K to 68.2 K (+4.92 %) |
| Jul 11 2018 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 1.17 | 4,273 | 4,999 | 65,032 | 60.8 K to 65 K (+7.03 %) |
| Jul 11 2018 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 1.17 | 4,273 | 4,999 | 65,032 | 60.8 K to 65 K (+7.03 %) |
| Jun 04 2018 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 0.75 | 53,326 | 40,000 | 60,759 | 7.4 K to 60.8 K (+717.42 %) |
| Apr 10 2018 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 1.36 | 653 | 888 | 7,433 | 6.8 K to 7.4 K (+9.63 %) |
| Mar 20 2018 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 0.00 | 6,780 | 0 | 6,780 | 0 to 6.8 K |
| Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Option Exercise | A | 59.14 | 10,000 | 591,400 | 10,000 | |
| Aug 11 2017 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Buy | P | 50.09 | 1,584 | 79,338 | 971,000 | 969.4 K to 971 K (+0.16 %) |
| Aug 11 2017 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Buy | P | 49.21 | 15,206 | 748,258 | 969,416 | 954.2 K to 969.4 K (+1.59 %) |
| Aug 11 2017 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Buy | P | 48.06 | 3,610 | 173,490 | 954,210 | 950.6 K to 954.2 K (+0.38 %) |
| Jan 06 2017 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Option Exercise | A | 84.92 | 10,000 | 849,200 | 10,000 | |
| Jul 06 2016 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Option Exercise | A | 41.01 | 10,000 | 410,100 | 10,000 | |
| Jan 04 2013 | JPM | JPMORGAN CHASE &am ... | Braunstein Douglas L | Chief Financial Off ... | Gift | G | 0.00 | 109,000 | 0 | 109,000 | 0 to 109 K |
| Jan 04 2013 | JPM | JPMORGAN CHASE &am ... | Braunstein Douglas L | Chief Financial Off ... | Gift | G | 0.00 | 24,000 | 0 | 24,000 | 0 to 24 K |
| Jan 04 2013 | JPM | JPMORGAN CHASE &am ... | Braunstein Douglas L | Chief Financial Off ... | Gift | G | 0.00 | 24,000 | 0 | 0 | 24 K to 0 (-100.00 %) |
| Jan 04 2013 | JPM | JPMORGAN CHASE &am ... | Braunstein Douglas L | Chief Financial Off ... | Gift | G | 0.00 | 24,000 | 0 | 24,000 | 0 to 24 K |
| Jan 04 2013 | JPM | JPMORGAN CHASE &am ... | Braunstein Douglas L | Chief Financial Off ... | Gift | G | 0.00 | 109,000 | 0 | 470,836 | 579.8 K to 470.8 K (-18.80 %) |
| Jan 04 2013 | JPM | JPMORGAN CHASE &am ... | Braunstein Douglas L | Chief Financial Off ... | Gift | G | 0.00 | 24,000 | 0 | 579,836 | 603.8 K to 579.8 K (-3.97 %) |
| Jan 20 2012 | JPM | JPMORGAN CHASE &am ... | Braunstein Douglas L | Chief Financial Off ... | Option Exercise | A | 35.61 | 168,729 | 6,008,440 | 168,729 | |
| Jan 20 2012 | JPM | JPMORGAN CHASE &am ... | Braunstein Douglas L | Chief Financial Off ... | Option Exercise | A | 0.00 | 122,174 | 0 | 122,174 | |
| Jan 18 2012 | JPM | JPMORGAN CHASE &am ... | Braunstein Douglas L | Chief Financial Off ... | Payment of Exercise | F | 35.53 | 92,149 | 3,273,593 | 603,836 | 696 K to 603.8 K (-13.24 %) |
| Jan 21 2011 | JPM | JPMORGAN CHASE &am ... | Braunstein Douglas L | Chief Financial Off ... | Option Exercise | A | 44.29 | 153,847 | 6,813,884 | 153,847 | |
| Jan 21 2011 | JPM | JPMORGAN CHASE &am ... | Braunstein Douglas L | Chief Financial Off ... | Option Exercise | A | 0.00 | 130,067 | 0 | 130,067 | |
| Jan 18 2011 | JPM | JPMORGAN CHASE &am ... | Braunstein Douglas L | Chief Financial Off ... | Payment of Exercise | F | 44.57 | 151,966 | 6,773,125 | 695,985 | 848 K to 696 K (-17.92 %) |
Page: 1